Evaluation of similar quality attribute characteristics in SB5 and reference product of adalimumab-Reference-Cited by-同舟云学术

Evaluation of similar quality attribute characteristics in SB5 and reference product of adalimumab

Published:2018-10-19 Issue:1 Volume:11 Page:129-144
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Lee Nayoung¹^ORCID,Lee JongAh Joanne²,Yang Hahymn¹^ORCID,Baek Serim¹^ORCID,Kim Soohwan¹,Kim Sooshin¹^ORCID,Lee Tongkeun¹^ORCID,Song Dami²,Park Gwangmin²

Affiliation:

1. Analytical Method Development Team, Samsung Bioepis Co., Ltd., Incheon, South Korea

2. Bioanalysis Team, Samsung Bioepis Co., Ltd., Incheon, South Korea

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/19420862.2018.1530920

Reference23 articles.

1. Biosimilars—why terminology matters

2. Strategies and challenges for the next generation of therapeutic antibodies

3. Tumor necrosis factor antagonist mechanisms of action: A comprehensive review

4. Acceptable changes in quality attributes of glycosylated biopharmaceuticals

5. Disulfide bond structures of IgG molecules

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of Critical Quality Attributes of an Anti-PCSK9 Monoclonal Antibody;Biologics;2024-09-11

2. Basic regulatory science behind drug substance and drug product specifications of monoclonal antibodies and other protein therapeutics;J PHARM ANAL;2024

3. Isolation and characterization of rabies monoclonal antibody charge variants;ELECTROPHORESIS;2024-05-03

4. Size exclusion chromatography as green support for forced degradation study of adalimumab;Acta Pharmaceutica;2023-12-01

5. Basic Regulatory Science Behind Drug Substance and Drug Product Specifications of Monoclonal Antibodies and Other Protein Therapeutics;Journal of Pharmaceutical Analysis;2023-12